Kate E. Duhig

TL;DR: The authors found that the availability of PlGF test results reduced the time to clinical confirmation of pre-eclampsia, and there was no evidence of a difference in perinatal adverse outcomes.

TL;DR: There is sparse evidence that supplementation with commonly used antioxidants (mostly vitamins C and E) makes any difference in overcoming oxidative stress or reversing disease processes, but there may be potential for antioxidant therapy to ameliorate or prevent disease.

TL;DR: New developments in diagnosis with a focus on angiogenic biomarkers for prediction of disease onset, and recent advances in management strategies for patients with pre-eclampsia are summarized.

TL;DR: To calculate the cost‐effectiveness of implementing PlGF testing alongside a clinical management algorithm in maternity services in the UK, compared with current standard care, a cost-effectiveness estimate was calculated.

TL;DR: The aim of the trial was to determine whether implementation of the CRADLE intervention into routine maternity care in place of existing equipment will reduce a composite outcome of maternal mortality and morbidity in low- and middle-income country populations.